Leading Business Funding Platform.  $115+ million in funds raised by entrepreneurs in the last 12 months*

The Cambridge Center For Medical & Veterinary Sciences Inc

Guelph, ON N1H 7R4, Canada
Healthcare
www.ccmvs.com

The Cambridge Center for Medical & Veterinary Sciences Inc. (CMVS) is focusing its efforts (PHASE ONE of the project) to raise USD 1.6 million for the purpose of establishing kidney transplant program for clinically diagnosed uremic dogs in Greater Toronto Area (GTA) in Ontario, Canada. This will be the first and only such program established in Canada and the U.S.A. In this PHASE ONE, the Company is planning to establish a new 2,500 sq. ft. – 5,000 sq. ft. FACILITY in GTA, where the clinical kidney transplant program for uremic dogs, a lifesaving procedure provided for terminally ill patients, and the staff involved in the transplant program can be incorporated. The FACILITY will provide an environment for generating a revenue (organ transplantation, daily routine in- & out- patient clinical work, auxiliary services, etc.) in the amount of USD 750.000 (very conservative approach) in its first operational year– and the return on investment. Currently, there are no clinical kidney transplant programs for dogs with diagnosed end-stage-kidney disease established in Canada and in the USA.
Approximately 2.25 million of our pets, dogs and cats (1.5% of total population of 150 million), are diagnosed every year with uremia and / or diabetes, of which 40% - 50% are euthanized due to lack of treatment . This licenced FACILITY will set-up a fundamental platform to create a teaching-learning institution as it has been outline in the Phase 2 of this project. GTA is a very unique and only such place (a strip 150 km long and 50 km wide along Lake of Ontario) on the North American continent due to its geography (Grate Lakes – 18 % of the world's fresh lake water), climate (mild winters and hot summers), population (most populous urban region in Canada, with over 5 million people and expected to add another 2.5 to 4 million by 2020), economy (revenue: C$21 billion / year, and rising), and education (numerous of highly educated individuals holding their PhD degrees).

General Information

 
 
 
 
 

Social Links

Company Industry

Select Industry:

Company Description

0 / 250
 
0 / 2000
 

Summary

Prior Year Revenue Current Year Revenue Next Year Revenue
Company Age Employees Sub-Industry
27 years, 6 months 2 Other Healthcare
Company Type Stock Exchange Stock Symbol
Privately-Held - -

Company Financials

Viewable by EquityNet investors only

Company Age & Size

Stock Exchange

Is this company privately-held or publicly-traded?

Products / Services

0 / 1000
Veterinary Transplant Services for Pets With the End-Stage of Kidney Disease

Services in the form of kidney transplant programs, routine in-&-out-patient clinical work, diagnostic work, etc. will be provided to approximately 9,000 clinical patients (dogs) diagnosed with the end stage of kidney disease in Greater Toronto Area (GTA), additionally to approximately 500,000 patients - dogs that are diagnosed every year in the USA with uremia of which 40%-50% are euthanized due to lack of treatment. There are approximately 1,500 hospitals in Ontario providing services to dogs and cats. It is anticipated that each hospital may refer to our FACILITY at least 1 patient / year

Pet Industry

Our FACILITY will be the 1st and only place in Ontario/Canada/USA to provide kidney transplant services to approximately 37,000 pets, dogs/cats (1.5% of total population of 2.5 million living in Greater Toronto Area), additionally to 2.25 million of pets (1.5% of total population of 150 million living in the USA) which are diagnosed every year with uremia / diabetes, of which 40% - 50% are euthanized due to lack of treatment. Pet Industry with spending on veterinary services, pet insurance, grooming, boarding, pet hotels, and pet-sitting is one of the fastest growing industry by 3%-4% per year

Management

0 / 1000
Director
Miroslaw P. Ruka

Miroslaw P. RukaMiroslaw P. Ruka (DVM, PhD) is licensed in the Province of Ontario as a Veterinary Clinical Small Animal Organ Transplant Surgeon, by the College of Veterinarians of Ontario (CVO, license no. 4796, Ontario, Canada), as an only such specialist in Ontario, and in Canada. He has gained his clinical, teaching, applied-clinical research experience with training in soft tissue surgery/microsurgery and organ-transplantation working in an academic environment of Eastern & Western Europe, Middle East, and North America. He is a recipient of two Post-Doctoral Fellowship Awards in the field of organ / tissue transplantation and reconstruction from Holland and Canada. He is also the winner of the best papers presented at the meetings of the European Society for Surgical Research and the Microscopical Society of Canada. He has published more than 80 scientific papers and abstracts in scientific and clinical journals in the field of organ transplantation and related immunology.

Director
Allan S. MacDonald

Dr. Allan S. MacDonald (M.D) is a Professor Emeritus of Surgery and Transplantation at Dalhousie University and the Queen Elisabeth II Health Sciences Center in Halifax. He is graduate in Medicine from Dalhousie University. He did his post-graduate surgical training in the Halifax hospitals with research and training at Harvard University under Professor J.E. Murray and the Cambridge University with Professor Sir R.Y. Calne. He established the kidney transplant program in Halifax in 1969 and has been involved in basic laboratory research in the fields of clinical transplantation and immunology ever since. He has over 250 scientific papers and abstracts published in scientific and clinical journals. He has supervised the introduction of liver / pancreas transplantation to the established kidney program. Dr. MacDonald is a Fellow of the Royal College of Physicians and Surgeons of Canada and has served as a Member of Council for the College eight years and as an examiner for seven years

Funding

0%

Funding Goal$1,600,000

Funding Raised So Far

Funding Commitments

Funding Remaining$1,600,000

Funding TypeEquity

Pre-Money Valuation

Investor Ownership

Interest / Dividend

Previous Funding

General Funding

Showing your General Funding information publicly may constitute general solicitation. General solicitation is a new commonly-used way for companies to raise funding. To learn about general solicitation, consult your legal counsel. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors.

Private Funding

Viewable by EquityNet investors only

Video

The Cambridge Center For Medical & Veterinary Sciences Inc Image 1
The Cambridge Center For Medical & Veterinary Sciences Inc Image 2
The Cambridge Center For Medical & Veterinary Sciences Inc Image 3
The Cambridge Center For Medical & Veterinary Sciences Inc Image 4
The Cambridge Center For Medical & Veterinary Sciences Inc Image 5
The Cambridge Center For Medical & Veterinary Sciences Inc Image 6
The Cambridge Center For Medical & Veterinary Sciences Inc Image 7
The Cambridge Center For Medical & Veterinary Sciences Inc Image 8
The Cambridge Center For Medical & Veterinary Sciences Inc Image 9

Images

Documents

Complete a Business Plan in EquityNet

Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Investors prefer an EquityNet business plan. Entering a plan is highly educational and improves your appeal to investors.

Upload Documents

Document file names will be viewable by EquityNet investors and business supporters only. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab.

Share Your Public Profile Page

Users who follow all these tips increase their fundraising odds substantially.

  • Email your public page to all your LinkedIn contacts.
    • Post your page to your LinkedIn profile page.
  • Email your public page to all your Facebook contacts.
    • Post your page to your Facebook profile page.
  • Email your public page to all your Twitter contacts.
    • Post your page to your Twitter profile page.
  • Put your public page up on your website.
    • Don't have a website yet? Use this page as your site!
  • Share your page link anywhere there's a listing for your company.
    • Press Releases, Crunchbase, Wikipedia, Blogs, etc...
  • Email your public page to all your email contacts.
    • Use Outlook, Gmail, Yahoo Mail, Hotmail, etc...

Your Public Profile Page:

Would you like to share your public profile page with your email contacts?